Your browser doesn't support javascript.
loading
Relevance of CYP3A4*20, UGT1A1*37 and UGT1A1*28 variants in irinotecan-induced severe toxicity.
Riera, Pau; Salazar, Juliana; Virgili, Anna C; Tobeña, María; Sebio, Ana; Gallano, Pía; Barnadas, Agustí; Páez, David.
Afiliação
  • Riera P; Genetics Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Salazar J; Faculty of Pharmacy and Food Sciences, Universitat de Barcelona (UB), Barcelona, Spain.
  • Virgili AC; Genetics Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Tobeña M; U705, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Barcelona, Spain.
  • Sebio A; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Gallano P; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Barnadas A; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Páez D; Genetics Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Br J Clin Pharmacol ; 84(6): 1389-1392, 2018 06.
Article em En | MEDLINE | ID: mdl-29504153

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Astenia / Neoplasias Colorretais / Glucuronosiltransferase / Diarreia / Citocromo P-450 CYP3A / Inibidores da Topoisomerase I / Variantes Farmacogenômicos / Irinotecano / Neutropenia Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Astenia / Neoplasias Colorretais / Glucuronosiltransferase / Diarreia / Citocromo P-450 CYP3A / Inibidores da Topoisomerase I / Variantes Farmacogenômicos / Irinotecano / Neutropenia Idioma: En Ano de publicação: 2018 Tipo de documento: Article